3E Bioventures Capital is an institutional investor (Conventional VCs) founded in 2015 and headquartered in Menlo Park, United States. Life science VC investing in biotech and techbio innovators. The firm focuses on investing in global leading health innovators within the biotech and techbio sectors. They target new drugs, new modalities, and drug discovery platforms, as well as the intersection of biology and technology. With a science-driven and entrepreneur-friendly investment philosophy, they collaborate closely with companies and research institutions to develop drugs or products addressing significant unmet medical needs. Their approach emphasizes expertise, efficiency, and execution, aiming to drive success in the life science industry. They are actively seeking business plans from innovative ventures.

Stage

Not disclosed

HQ

Beijing, china

Founded

2015

Website

https://3ebiovc.com

LinkedIn

https://linkedin.com/company/3e-bioventures-capital

Preparing to pitch 3E Bioventures Capital?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.